Tier 2 — strong
Single-Dose Creatine Reduces Sleep Deprivation-Induced Deterioration in Cognitive Performance
Nutrients
2026
18(8):1192
Bibliography
- PubMed
- PMID 42075005
- PubMed Central
- PMC13119191
- Funding
- Expenses for the study and personnel budgets were financed by Forschungszentrum Jülich, Germany.
- Competing interests
- No explicit competing-interests statement was located in the accessible PubMed or publisher records during Biohack Blueprint's 2026-10-02 audit. This is an audit-status statement, not confirmation that no competing interests existed.
Study snapshot
| Design | Randomized placebo-controlled human intervention study |
|---|---|
| Model | Human |
| Sample | 29 healthy adults |
| Intervention | Single 0.2 g/kg dose of creatine monohydrate or placebo during 21 hours of sleep deprivation |
| Duration | Acute; 21-hour sleep-deprivation protocol |
| Endpoints | Logical reasoning; Numerical processing; Language processing speed; Psychomotor vigilance |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Creatine Brain Benefits: Memory, Cognition, Sleep Loss and What Is Still UncertainCreatine and the brain: evidence for memory, attention, processing speed, older adults and stressed states—plus why recent systematic reviews disagree.Read analysis
- Creatine for Women: Benefits, Safety, Dose and Life-Stage EvidenceCreatine for women across training, menstruation, menopause and brain health: what female-specific studies show, where evidence is promising and where it remains...Read analysis
- Creatine Benefits: Strength, Muscle, Brain and Healthy Aging EvidenceThe benefits of creatine separated by evidence strength: strength, lean mass, performance, women, older adults and cognition.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
